• PDF: Delivered by email usually within 12 to 48 UK business hours.

Rheumatology Therapeutics Market to 2018
Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

  • Publication Date:December 2012
  • Publisher:GBI Research
  • Product Type: Report
  • Pages:120

Rheumatology Therapeutics Market to 2018 Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth

Summary

GBI Research, the leading business intelligence provider, has released its latest research, 'Rheumatology Therapeutics Market to 2018 - Increasing Uptake of Benlysta, Uloric, Krystexxa, and the Launch of Oral Tofacitinib to Spur Growth'. The report provides insights into the rheumatology therapeutics market forecasts until 2018 and examines global treatment usage patterns for various rheumatology disorders. It also looks at the geographical distribution of the rheumatology disorders therapeutics market across key geographies (the US, the top five countries of Europe, and Japan) and provides insights into the R&D pipeline and promising future blockbusters until 2018. The report also profiles major biopharmaceutical companies in the segment and analyzes M&A activity and licensing agreements.

The reports covers Rheumatoid Arthritis (RA), Osteoarthritis (OA), Systemic Lupus Erythematosus (SLE) and gout, as these are most prevalent forms of rheumatologic disease. The global rheumatology therapeutics market was estimated to be worth $17.1 billion in 2011, having grown at a Compound Annual Growth Rate (CAGR) of 9.4% from 2005, and is forecast to grow at a CAGR of 4.8% to $23.8 billion by 2018.

Enbrel (etanercept), Humira (adalimumab) and Remicade (infliximab) are the major drugs used in rheumatology therapeutics. Enbrel and Humira account for the majority of the market in the US. Enbrel's patent is set to expire in October 2012, although this is not expected to have an immediate impact as biosimilars are not predicted to enter the market until 2016-2017. In March 2011, the Food and Drug Administration (FDA) approved Benlysta (belimumab) for the treatment of SLE and in July 2011, it was approved by the European Medicines Agency (EMA).

Scope

  • Data and analysis for the rheumatology therapeutics market in the leading geographies of the world: the US, the UK, Germany, France, Italy, Spain and Japan
  • Annualized market data for the rheumatology therapeutics market from 2005 to 2011, forecast to 2018
  • In-depth analysis of the acute and chronic rheumatology therapeutics markets
  • Market data for the geographical and therapeutic landscapes, including size, annual cost of therapy, revenues, and treatment usage patterns for the diseased population, treatment-seeking population, diagnosed population and prescription population
  • Key drivers and barriers that have had a significant impact on the market
  • Profiles of major biopharmaceutical markets in the rheumatology therapeutics segment, namely AstraZeneca, Eli Lilly, Pfizer, Janssen Biotech and UCB
  • Key M&A activity and licensing agreements from 2007 to April 2012 in the rheumatology therapeutics market

Reasons to buy

  • Build effective strategies for launching pipeline products by identifying potential geographies
  • Exploit in-licensing and out-licensing opportunities by identifying products to fill portfolio gaps
  • Develop key strategic initiatives by studying top competitors' key strategies
  • Develop market-entry and market-expansion strategies by identifying the geographic markets poised for strong growth
  • 1 Table of Contents
    • 1.1 List of Tables
    • 1.2 List of Figures
  • 2 Rheumatology Therapeutics Market to 2018 - Introduction
    • 2.1 Introduction
  • 3 Rheumatology Therapeutics Market to 2018 - Market Overview
    • 3.1 Introduction
      • 3.1.1 Revenue
      • 3.1.2 Annual Cost of Treatment
      • 3.1.3 Treatment Usage Pattern
  • 4 Rheumatology Therapeutics Market to 2018 - Geographical Landscape Revenue Analysis by Geography
    • 4.1 The US
      • 4.1.1 Revenue
      • 4.1.2 Annual Cost of Treatment
      • 4.1.3 Treatment Usage Patterns
    • 4.2 Top Five Countries of Europe
      • 4.2.1 Introduction
      • 4.2.2 Revenue
      • 4.2.3 Annual Cost of Treatment
      • 4.2.4 Treatment Usage Patterns
    • 4.3 Japan
      • 4.3.1 Revenue
      • 4.3.2 Annual Cost of Treatment
      • 4.3.3 Treatment Usage Patterns
    • 4.4 Australia
      • 4.4.1 Overview of Rheumatology Market
    • 4.5 China
      • 4.5.1 Revenue
    • 4.6 India
      • 4.6.1 Overview of Rheumatology Market
  • 5 Rheumatology Therapeutics Market to 2018 - Therapeutic Landscape
    • 5.1 Rheumatoid Arthritis Therapeutics Market
      • 5.1.1 Introduction
      • 5.1.2 Revenue
      • 5.1.3 Revenue by Country
      • 5.1.4 Annual Cost of Treatment
      • 5.1.5 Treatment Usage Pattern
      • 5.1.6 Treatment Flow Algorithm
      • 5.1.7 Drivers and Barriers for the Rheumatoid Arthritis Therapeutics Market
    • 5.2 Osteoarthritis Therapeutics Market
      • 5.2.1 Introduction
      • 5.2.2 Revenue
      • 5.2.3 Revenue by Country
      • 5.2.4 Annual Cost of Treatment
      • 5.2.5 Treatment Flow Algorithm
      • 5.2.6 Treatment Usage Pattern
      • 5.2.7 Drivers and Barriers for the Osteoporosis Therapeutics Market
    • 5.3 Gout Therapeutics Market
      • 5.3.1 Introduction
      • 5.3.2 Revenue
      • 5.3.3 Revenue by Country
      • 5.3.4 Annual Cost of Treatment
      • 5.3.5 Treatment Usage Pattern
      • 5.3.6 Treatment Flow Algorithm
      • 5.3.7 Drivers and Barriers for the Gout Therapeutics Market
    • 5.4 Systemic Lupus Erythematosus Therapeutics Market
      • 5.4.1 Introduction
      • 5.4.2 Revenue
      • 5.4.3 Annual Cost of Treatment
      • 5.4.4 Treatment Usage Pattern
      • 5.4.5 Treatment Flow Algorithm
      • 5.4.6 Drivers and Barriers for Systemic Lupus Erythematosus Therapeutics Market
  • 6 Rheumatology Therapeutics Market to 2018 - Pipeline Analysis
    • 6.1 Pipeline Assessment by Clinical Phase of Development
    • 6.2 Key R&D Trends and Future Outlook
    • 6.3 Profiles of Promising Molecules
      • 6.3.1 Tofacitinib
      • 6.3.2 Fostamatinib
      • 6.3.3 LY2127399 (tabalumab)
      • 6.3.4 Naproxcinod
      • 6.3.5 RDEA594 (lesinurad)
      • 6.3.6 BCX4208
      • 6.3.7 Epratuzumab
      • 6.3.8 Lupuzor
      • 6.3.9 Atacicept
  • 7 Rheumatology Therapeutics Market to 2018 - Competitive Landscape
    • 7.1 Abbott
      • 7.1.1 Overview
      • 7.1.2 Major Marketed Products
      • 7.1.3 SWOT Analysis
    • 7.2 Amgen
      • 7.2.1 Overview
      • 7.2.2 Major Marketed Products
      • 7.2.3 SWOT Analysis
    • 7.3 Pfizer
      • 7.3.1 Overview
      • 7.3.2 Major Marketed Products
      • 7.3.3 SWOT Analysis
    • 7.4 Janssen Biotech
      • 7.4.1 Overview
      • 7.4.2 Major Marketed Products
      • 7.4.3 SWOT Analysis
    • 7.5 Merck
      • 7.5.1 Overview
      • 7.5.2 Major Marketed Products
      • 7.5.3 SWOT Analysis
  • 8 Rheumatology Therapeutics Market to 2018 - Strategic Consolidations
    • 8.1 Overview
      • 8.1.1 Deals by Type of Agreement
      • 8.1.2 Deals by Year
      • 8.1.3 Deals by Geography
      • 8.1.4 Profiling of Major Deals
  • 9 Rheumatology Therapeutics Market - Appendix
    • 9.1 Market Definitions
    • 9.2 Abbreviations
    • 9.3 Bibliography
    • 9.4 Research Methodology
      • 9.4.1 Coverage
      • 9.4.2 Secondary Research
      • 9.4.3 Primary Research
    • 9.5 Therapeutic Landscape
      • 9.5.1 Epidemiology-based Forecasting
      • 9.5.2 Market Size by Geography
    • 9.6 Geographical Landscape
    • 9.7 Pipeline Analysis
    • 9.8 Competitive Landscape
      • 9.8.1 Expert Panel Validation
    • 9.9 Contact Us
    • 9.10 Disclaimer
  • 1.1 List of Tables
    • Table 1: Rheumatology Therapeutics Market, Global, Revenue ($bn), 2005-2011
    • Table 2: Rheumatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
    • Table 3: Rheumatology Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2011
    • Table 4: Rheumatology Therapeutics Market, Global, Annual Cost of Therapy ($), 2011-2018
    • Table 5: Rheumatology Therapeutics Market, Global, Treatment Usage Patterns (million), 2005-2011
    • Table 6: Rheumatology Therapeutics Market, Global, Treatment Usage Patterns (million), 2011-2018
    • Table 7: Rheumatology Therapeutics Market, The US, Revenue ($bn), 2005-2011
    • Table 8: Rheumatology Therapeutics Market, The US, Revenue Forecasts ($bn), 2011-2018
    • Table 9: Rheumatology Therapeutics Market, The US, Annual Cost of Therapy ($), 2005-2011
    • Table 10: Rheumatology Therapeutics Market, The US, Annual Cost of Therapy ($), 2011-2018
    • Table 11: Rheumatology Therapeutics Market, The US, Treatment Usage Patterns (million), 2005-2011
    • Table 12: Rheumatology Therapeutics Market, The US, Treatment Usage Patterns (million), 2011-2018
    • Table 13: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue ($bn), 2005-2011
    • Table 14: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($bn), 2011-2018
    • Table 15: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue ($m), 2005-2011
    • Table 16: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2011-2018
    • Table 17: Rheumatology Therapeutics Market, Top Five Countries of Europe, Annual Cost of Therapy ($), 2005-2011
    • Table 18: Rheumatology Therapeutics Market, Top Five Countries of Europe, Annual Cost of Therapy ($), 2011-2018
    • Table 19: Rheumatology Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (million), 2005-2011
    • Table 20: Rheumatology Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (million), 2011-2018
    • Table 21: Rheumatology Therapeutics Market, Japan, Revenue ($bn), 2005-2011
    • Table 22: Rheumatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2011-2018
    • Table 23: Rheumatology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2005-2011
    • Table 24: Rheumatology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2011-2018
    • Table 25: Rheumatology Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2005-2011
    • Table 26: Rheumatology Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2011-2018
    • Table 27: Rheumatoid Arthritis Therapeutics Market, Global, Revenue ($bn), 2005-2011
    • Table 28: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
    • Table 29: Rheumatoid Arthritis Therapeutics Market, Global, Revenue by Country ($m), 2005-2011
    • Table 30: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2011-2018
    • Table 31: Rheumatoid Arthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2011
    • Table 32: Rheumatoid Arthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2011-2018
    • Table 33: Rheumatoid Arthritis Therapeutics Market, Global, Treatment Usage Pattern (million), 2005-2011
    • Table 34: Rheumatoid Arthritis Therapeutics Market, Global, Treatment Usage Pattern (million), 2011-2018
    • Table 35: Osteoarthritis Therapeutics Market, Global, Revenue ($bn), 2005-2011
    • Table 36: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2011-2018
    • Table 37: Osteoarthritis Therapeutics Market, Global, Revenue ($m), 2005-2011
    • Table 38: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($m), 2011-2018
    • Table 39: Osteoarthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2011
    • Table 40: Osteoarthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2011-2018
    • Table 41: Osteoarthritis Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005-2011
    • Table 42: Osteoarthritis Therapeutics Market, Global, Treatment Usage Pattern (millions), 2011-2018
    • Table 43: Gout Therapeutics Market, Global, Revenue ($m), 2005-2011
    • Table 44: Gout Therapeutics Market, Global, Revenue Forecasts ($m), 2011-2018
    • Table 45: Gout Therapeutics Market, Global, Revenue by Country ($m), 2005-2011
    • Table 46: Gout Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2011-2018
    • Table 47: Gout Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2011
    • Table 48: Gout Therapeutics Market, Global, Annual Cost of Therapy ($), 2011-2018
    • Table 49: Gout Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005-2011
    • Table 50: Gout Therapeutics Market, Global, Treatment Usage Pattern (millions), 2011-2018
    • Table 51: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue ($m), 2005-2011
    • Table 52: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts ($m), 2011-2018
    • Table 53: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue by Country ($m), 2005-2011
    • Table 54: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2011-2018
    • Table 55: Systemic Lupus Erythematosus Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2011
    • Table 56: Systemic Lupus Erythematosus Therapeutics Market, Global, Annual Cost of Therapy ($), 2011-2018
    • Table 57: Systemic Lupus Erythematosus Therapeutics Market, Global, Treatment Usage Pattern ('000), 2005-2011
    • Table 58: Systemic Lupus Erythematosus Therapeutics Market, Global, Treatment Usage Pattern ('000), 2011-2018
    • Table 59: Rheumatology Therapeutics Market, Global, Deals by Type of Agreement (%), 2007-2012
    • Table 60: Rheumatology Therapeutics Market, Global, Deals by Geography (%), 2007-2012
  • 1.2 List of Figures
    • Figure 1: Rheumatology Therapeutics Market, Global, Revenue Forecasts ($bn), 2005-2018
    • Figure 2: Rheumatology Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2018
    • Figure 3: Rheumatology Therapeutics Market, Global, Treatment Usage Patterns (million), 2005-2018
    • Figure 4: Rheumatology Therapeutics Market, The US, Revenue Forecasts ($bn), 2005-2018
    • Figure 5: Rheumatology Therapeutics Market, The US, Annual Cost of Therapy ($), 2005-2018
    • Figure 6: Rheumatology Therapeutics Market, The US, Treatment Usage Patterns (million), 2005-2018
    • Figure 7: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($bn), 2005-2018
    • Figure 8: Rheumatology Therapeutics Market, Top Five Countries of Europe, Revenue Forecasts ($m), 2005-2018
    • Figure 9: Rheumatology Therapeutics Market, Top Five Countries of Europe, Annual Cost of Therapy ($), 2005-2018
    • Figure 10: Rheumatology Therapeutics Market, Top Five Countries of Europe, Treatment Usage Patterns (million), 2005-2018
    • Figure 11: Rheumatology Therapeutics Market, Japan, Revenue Forecasts ($bn), 2005-2018
    • Figure 12: Rheumatology Therapeutics Market, Japan, Annual Cost of Therapy ($), 2005-2018
    • Figure 13: Rheumatology Disorders Therapeutics Market, Japan, Treatment Usage Patterns (millions), 2005-2018
    • Figure 14: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2005-2018
    • Figure 15: Rheumatoid Arthritis Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2005-2018
    • Figure 16: Rheumatoid Arthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2018
    • Figure 17: Rheumatoid Arthritis Therapeutics Market, Global, Treatment Usage Pattern (million), 2005-2018
    • Figure 18: Rheumatoid Arthritis Therapeutics Market, Rheumatoid Arthritis, Treatment Flow Algorithm
    • Figure 19: Rheumatoid Arthritis Therapeutics Market, Drivers and Barriers
    • Figure 20: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($bn), 2005-2018
    • Figure 21: Osteoarthritis Therapeutics Market, Global, Revenue Forecasts ($m), 2005-2018
    • Figure 22: Osteoarthritis Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2018
    • Figure 23: Osteoarthritis Therapeutics Market, Global, Osteoarthritis Pain Treatment Algorithm
    • Figure 24: Osteoarthritis Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005-2018
    • Figure 25: Osteoarthritis Therapeutics Market, Global, Drivers and Barriers
    • Figure 26: Gout Therapeutics Market, Global, Revenue Forecasts ($m), 2005-2018
    • Figure 27: Gout Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2005-2018
    • Figure 28: Gout Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2018
    • Figure 29: Gout Therapeutics Market, Global, Treatment Usage Pattern (millions), 2005-2018
    • Figure 30: Gout Therapeutics Market, Treatment Flow Algorithm for Gout
    • Figure 31: Gout Therapeutics Market, Global, Drivers and Barriers
    • Figure 32: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts ($m), 2005-2018
    • Figure 33: Systemic Lupus Erythematosus Therapeutics Market, Global, Revenue Forecasts by Country ($m), 2005-2018
    • Figure 34: Systemic Lupus Erythematosus Therapeutics Market, Global, Annual Cost of Therapy ($), 2005-2018
    • Figure 35: Systemic Lupus Erythematosus Therapeutics Market, Global, Treatment Usage Pattern ('000), 2005-2018
    • Figure 36: Systemic Lupus Erythematosus Therapeutics Market, Treatment Flow Algorithm
    • Figure 37: Systemic Lupus Erythematosus Therapeutics Market, Global, Drivers and Barriers
    • Figure 38: Rheumatology Therapeutics Market, Global, Pipeline Molecules by Stage of Development, May, 2012
    • Figure 39: Rheumatology Therapeutics Market, Abbott, SWOT Analysis
    • Figure 40: Rheumatology Therapeutics Market, Amgen, SWOT Analysis
    • Figure 41: Rheumatology Therapeutics Market, Pfizer, SWOT Analysis
    • Figure 42: Rheumatology Therapeutics Market, Janssen Biotech, SWOT Analysis
    • Figure 43: Rheumatology Therapeutics Market, Merck, SWOT Analysis
    • Figure 44: Rheumatology Therapeutics Market, Global, Deals by Type of Agreement (%), 2007-2012
    • Figure 45: Rheumatology Therapeutics Market, Global, Deals by Year, 2007-2012
    • Figure 46: Rheumatology Therapeutics Market, Global, Deals by Geography (%), 2007-2012
    • Figure 47: GBI Research Market Forecasting Model
+44 20 8816 8548

Ask a question about Rheumatology Therapeutics Market to 2018

Enter the characters you see in the picture below
Captcha